It was with great sadness we received the message that our board member Lars Hellgren passed away on June 4th, after nearly two years of fighting against cancer.
Lars has been a huge contributor to our society for many years. He entered the board of Nordic Lipidforum back in 2003, acted Chair between 2007 and 2009, and attended his last board meeting late autumn 2016. Lars´ enthusiasm, great ideas and professional attitude has throughout this whole period been invaluable.
Lars was since 1997 employed at DTU, where he was a highly appreciated teacher and scientist. He was teaching at all levels from bachelor to PhD courses and always with great passion. Within his scientific career, Lars specialized in nutritional aspects of lipids, and focused particularly on the metabolism of ceramides and sphingomyelin in cell membranes. Later on his focus increasingly turned to the role of lipids for metabolic regulations in relation to metabolic diseases. In 2015 Lars, initiated and coordinated the InfantBrain project engaging both industry and academia in Denmark and he had great expectation for this project, which he had worked so hard to get funding for.
Within The Nordic Lipidforum, Lars great passion for teaching and transfer of knowledge made him deeply engage in the development of the Lipidforum Academy, which was held for the first time before the EFL/Lipidforum symposia i Göteborg, 2007. With help from Lars hard work, the Nordic Lipidforum Academy has since then been a highly successful bi-annual event. Lars’ good spirit together with his social skills, competence and large network has however not only been a huge asset for the Nordic Lipidforum Academy, but also for other events such as symposia and seminars. Not least, his input and help in organizing the upcoming EFL/Lipidforum symposia in August has been of great value, and will be in our minds in Uppsala when we carry through this event.
Lars, we will never forget your big smile, your overwhelming laughter and warm attendance. We all feel proud that we had a chance to work with you.
Our thoughts go to his son August, Marie, and to the rest of his family in this very difficult period.
Please also see the obituary of Lars Hellgren from DTU on their homepage here.
We would like to share some very important updates and information about the 15th EFL Congress and the 29th Nordic Lipidforum Symposium, which takes place in Uppsala, Sweden, August 27-30th.
- The full program and conference brochure is now available online here.
- Abstracts for posters are still welcome. Submission closes 1st July.
- We have opened a possibility to hold a 1 min oral poster pitch during poster sessions (PhD-students prioritized)
- Early Bird registration fee for the conference still applicable. Deadline is 14th July.
- Registration has also opened for our pre-conference event; the Nordic Lipidforum Academy, a 4-day course about lipid science and technology for PhD-students and employees in the fats and oils industry. More information is available at our website here.
For registration and further information about the EFL congress/Nordic Lipidforum Symposium, please go to Euro Fed Lipids website here.
We very much look forward to see you all in Uppsala in August!
Best; Ingrid Undeland, Bengt Herslöf and Robert Wolff
Registration for the Nordic Lipidforum Academy is now open!
Please follow this link to a Google Form, and fill in your data.
Prior to the 15th Euro Fed Lipid Congress and the 29th Nordic Lipidforum Symposium in Uppsala, Sweden, it is a pleasure to invite you all to another Nordic Lipidforum Academy. The introductory course will be given at the Uppsala University from Wednesday 23th to Sunday 27th of August 2017.
Nordic Lipidforum academy is an introductory course in lipid Science and technology for Ph.D. students and employees in the fats and oil industry.
Relevant information, program and details will be announced on our website.
The organising committe consist of:
Anna-Maija Lampi, University of Helsinki
Astrid Nilsson, NOFIMA
Robert Wolff, secretary Nordic Lipidforum
Kumari Ubhayasekera, researcher at Uppsala University
Our sponsorship and marketing for the 29th Nordic Lipidforum Symposium and the 15th Euro Fed Lipid Congress 2017 gives you the opportunity to support the organization of the congress and to highly promote your business. Besides increasing visibility, our sponsorship opportunities will help you to generate leads and add value to your corporate and brand image.
All our sponsors will be recommended in the registration program booklet, the book of abstract, on the congress webpage and special event signage. Early deciders enjoy a longer visibility. For more information, follow link here.
For tailor-made offers, please contact the headquarters (firstname.lastname@example.org).
The scientific committee now accepts lecture and poster abstracts. To submit your contribution, you will have to enter the Eurofed Lipid website. Please follow the link here. You will find all necessary information to submit the call at this website.
Deadline for lecture abstracts is 3 February 2017. For poster abstracts, to be included in the printed programme and last minute lectures, the deadline is 21 February 2017.
Friday 3 June 2016 Karin Larsson defended her PhD thesis at the Department of Biology and Biological Engineering – Food and Nutrition Science, Chalmers University of Technology. The title of her work was Oxidation of fish lipids during gastrointestinal in vitro digestion. Prof. Ingrid Undeland has been Karin’s superviser, and Prof. Marie Alminger secondary supervisor. Abstract of Karin’s thesis is available here.
Our goal in Nordic Lipidforum is to be relevant for our members. We want to promote applied research and technology, be a contact network, provide information about network playground for Nordic and international meetings, to inspire talented employees to increase their competence in lipid science and development, and much more. This is only possible with active members that share news and relevant activities. If you want to share something you believe is of importance, do not hasitate to contact secretary or members of the board.
The Nordic Lipidforum is now present at LinkedIn, so sign up the group today.
We are a small «lipid family» in the Nordic countries. Everyone knows everyone. Almost. The number of members in Nordic Lipidforum has been relatively stable for years, but with a slight decline. In time of globalisation, we are happy to see that our presence also is taken notice of outside the Nordic countries. We have now members from Peru as well!
If you know someone, either a colleague or two, a friend or professional contact, that might be interested in joining the Nordic Lipidforum, just ask them to sign up. You will find information about membership fee and an online application form here.
We hereby request all members to pass forward our website to people they believe might be interested in, and advantage of joining Nordic Lipidforum. Let us set a goal of 50 more members by the end of 2016!
On the January 29th an animal study from University of Gothenburg showing increased cancer growth in mice supplemented with Vitamin E and N-acetylcystein, was published in Science Translational Medicine1. The study shows that tumour progression is markedly increased and survival time decreased in mice which were given the antioxidants after initiation of tumour development. These results are in accordance with earlier human studies, showing that smokers taking -carotene supplements had higher lung cancer incidence than smokers not taking any supplementation2. Data from the recent study indicate that the anti-oxidants protects the cancer-cells from the normal, reactive-oxygen species based defence system, that are used by the body to kill cancer cells. It does however not say anything on whether anti-oxidant supplements can increase protection of cancer formation, only that already established cancer-cells have increased survival and drive increased tumour progression.
1. Sayin, V. I. et al. Sci. Transl. Med. 6, 221ra15 (2014).4
2. The Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group N. Engl. J. Med. 330, 1029–1035 (1994).